Amoy Diagnostics Co Ltd is a China-based company mainly providing tumor gene testing services. The Company mainly operates three businesses. The testing reagent business is engaged in the research, development and production of reagents such as gene mutation detection kits, human microsatellite instability (MSI) detection kits, human B-Raf proto-oncogene (BRAF) V600E mutation detection kits and estrogen receptor antibody reagents. The testing services business mainly provides medical testing services to pharmaceutical companies and research institutions. The drug clinical research services business mainly provides central laboratory testing and companion diagnostic registration services to pharmaceutical companies. The Company is also engaged in the research, development and production of human 12-gene mutation analysis software, as well as supporting instruments such as gene sequencers, fully automated nucleic acid extractors and fully automated immunohistochemical staining machines.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
